NASDAQ:NRC

National Research (NRC) Stock Forecast, Price & News

$44.61

-0.73 (-1.61%)

(As of 01:47 PM ET)

Compare

Today's Range: $44.61
▼
$45.65
50-Day Range: $41.80
▼
$46.78
52-Week Range: $34.69
▼
$47.60

Volume: 7,406 shs
Average Volume: 35,849 shs
Market Capitalization: $1.10 billion

P/E Ratio: 38.13
Dividend Yield: 1.08%
Price Target: N/A

National Research MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
1.89% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.75
Based on 6 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.40 out of 5 stars

Business Services Sector

241st out of 317 stocks

Commercial Physical Research Industry

13th out of 14 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for National Research.

2.0

Short Interest

Percentage of Shares Shorted
1.89% of the float of National Research has been sold short.
Short Interest Ratio / Days to Cover
National Research has a short interest ratio ("days to cover") of 9.7.
Change versus previous month
Short interest in National Research has recently increased by 163.21%, indicating that investor sentiment is decreasing significantly.

1.7

Dividend Strength

Dividend Yield
National Research pays a meaningful dividend of 1.04%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
National Research does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of National Research is 41.03%. This payout ratio is at a healthy, sustainable level, below 75%.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NRC.

2.6

News and Social Media Coverage

News Sentiment
National Research has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for National Research this week, compared to 2 articles on an average week.
Search Interest
1 people have searched for NRC on MarketBeat in the last 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, National Research insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.40% of the stock of National Research is held by insiders.
Percentage Held by Institutions
47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of National Research is 38.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 114.72.
Price to Earnings Ratio vs. Sector
The P/E ratio of National Research is 38.75, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 29.45.
Price to Book Value per Share Ratio
National Research has a P/B Ratio of 15.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About National Research (NASDAQ:NRC) Stock

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

NRC Price History

30 days | 90 days | 365 days | Advanced Chart

NRC Stock News Headlines

September 26, 2023 | finance.yahoo.com

Lurie Children’s expands partnership with NRC Health to gain valuable consumer insights

September 21, 2023 | news.yahoo.com

Government approves £105m Stanford Hall NHS rehabilitation centre

September 27, 2023 | Edge On The Street (Ad)

Is Gold Really Boring?

Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.

September 21, 2023 | msn.com

Government approves £105m NHS rehabilitation centre

September 17, 2023 | americanbankingnews.com

National Research (NASDAQ:NRC) Shares Gap Down to $46.15

September 15, 2023 | finance.yahoo.com

Unveiling National Research Corp's Dividend Profile: A Comprehensive Analysis

September 7, 2023 | finance.yahoo.com

Unveiling National Research (NRC)'s Value: Is It Really Priced Right? A Comprehensive Guide

September 6, 2023 | finance.yahoo.com

National Research Corporation Declares Special Dividend

September 27, 2023 | Wall Street Fundamentals (Ad)

The "Plug and Play" Model Putting Online Giants to Shame

While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."

August 31, 2023 | finance.yahoo.com

NRC Health emphasizes its commitment to ICD’s annual Patient Experience Symposium

August 29, 2023 | finance.yahoo.com

LifeBridge Health selects NRC Health as its new patient experience partner

August 29, 2023 | finance.yahoo.com

Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate Phase 2/3 Clinical Trial in Long COVID

August 27, 2023 | finance.yahoo.com

National Research's (NASDAQ:NRC) investors will be pleased with their 28% return over the last year

August 15, 2023 | seekingalpha.com

National Research: Economics Well Priced In, Future Value May Be Crimped (Rating Downgrade)

August 14, 2023 | msn.com

PureHealth to integrate National Rehabiltation Center in Abu Dhabi into its network

August 8, 2023 | finance.yahoo.com

NRC Health unveils winners of 2023 patient experience and loyalty awards

August 3, 2023 | powermag.com

Two Big Nuclear Regulatory Milestones for Idaho NuScale SMR Project

August 1, 2023 | finance.yahoo.com

National Research Corporation Announces Second Quarter 2023 Results

July 29, 2023 | finanznachrichten.de

Acuva Technologies Inc.: Acuva Secures Funding for R&D Project Through Innovative Solutions Canada

July 28, 2023 | markets.businessinsider.com

Vogtle Unit 4 has received the 103(g) finding from the Nuclear Regulatory Commission

July 28, 2023 | finance.yahoo.com

Acuva Secures Funding for R&D Project Through Innovative Solutions Canada

July 21, 2023 | msn.com

All ITAACs have been submitted for Plant Vogtle Unit 4

July 18, 2023 | finance.yahoo.com

National Research Corporation to Broadcast its 2023 Second Quarter Conference Call Live on the Internet

July 14, 2023 | fool.com

National Research (NASDAQ: NRC)

July 12, 2023 | finance.yahoo.com

Bryan Health Chooses NRC Health as Patient Experience Partner

July 11, 2023 | finance.yahoo.com

Next Hydrogen recipient of funding for technology development

July 5, 2023 | msn.com

Wanted: A Clear-Cut Policy on Immigration

See More Headlines

Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

NRC Company Calendar

Last Earnings: 8/01/2023
Ex-Dividend for 9/22 Dividend: 9/15/2023
Dividend Payable: 9/22/2023
Today: 9/27/2023
Ex-Dividend for 10/13 Dividend: 9/28/2023
Dividend Payable: 10/13/2023
Next Earnings (Estimated): 11/07/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Business Services
Current Symbol: NASDAQ:NRC
CUSIP: N/A
CIK: 70487
Web: www.nrchealth.com
Phone: (402) 475-2525
Fax: 402-475-9061
Employees: 491
Year Founded: 1981

Profitability

EPS (Most Recent Fiscal Year): $1.17
Trailing P/E Ratio: 38.14
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $31.80 million
Net Margins: 19.65%
Pretax Margin: 26.11%
Return on Equity: 39.94%
Return on Assets: 21.88%

Debt

Debt-to-Equity Ratio: 0.20
Current Ratio: 1.21
Quick Ratio: 1.21

Sales & Book Value

Annual Sales: $151.57 million
Price / Sales: 7.23
Cash Flow: $1.46 per share
Price / Cash Flow: 30.51
Book Value: $2.92 per share
Price / Book: 15.28

Miscellaneous

Outstanding Shares: 24,570,000
Free Float: 23,978,000
Market Cap: $1.10 billion
Optionable: Not Optionable
Beta: 0.48

Social Links

The Best High-Yield Dividend Stocks for 2023

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Michael D. Hays (Age 68)
Founder, CEO, Pres & Director
Comp: $131.65k

Mr. Kevin R. Karas C.P.A. (Age 65)
CPA, Sr. VP of Fin., CFO, Treasurer & Sec.
Comp: $292.81k

Ms. Jona S. Raasch (Age 64)
Chief Operating Officer
Comp: $308.01k

Ms. Helen L. Hrdy (Age 58)
Chief Growth Officer
Comp: $291.31k

Mr. Jon Boumstein
Chief Delivery Officer

Dr. Gregory Makoul M.S.
Ph.D., Chief Transformation Officer

Linda Stacy
VP of Fin.

Megan Charko
Sr. Mang. of Content Marketing

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NRC Stock - Frequently Asked Questions

How have NRC shares performed in 2023?: National Research's stock was trading at $37.30 at the beginning of 2023. Since then, NRC shares have increased by 19.6% and is now trading at $44.62.
View the best growth stocks for 2023 here.
Are investors shorting National Research?: National Research saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 271,900 shares, an increase of 163.2% from the August 31st total of 103,300 shares. Based on an average daily volume of 27,900 shares, the short-interest ratio is currently 9.7 days. Currently, 1.9% of the shares of the company are short sold.
View National Research's Short Interest.
When is National Research's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our NRC earnings forecast.
How were National Research's earnings last quarter?: National Research Co. (NASDAQ:NRC) announced its quarterly earnings results on Tuesday, August, 1st. The company reported $0.29 EPS for the quarter. The firm had revenue of $36.16 million for the quarter. National Research had a net margin of 19.65% and a trailing twelve-month return on equity of 39.94%.
How often does National Research pay dividends? What is the dividend yield for National Research?: National Research announced a None dividend on Wednesday, September 6th. Investors of record on Monday, September 18th will be paid a dividend of $1.00 per share on Friday, September 22nd. The ex-dividend date is Friday, September 15th.
Read our dividend analysis for NRC.
What ETF holds National Research's stock ?: Small Cap US Equity Select ETF holds 16,946 shares of NRC stock, representing 2.76% of its portfolio.
Is National Research a good dividend stock?: National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.04%. The dividend payout ratio is 41.03%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NRC.
What is Michael D. Hays' approval rating as National Research's CEO?: 85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees.

What other stocks do shareholders of National Research own?: Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD).
What is National Research's stock symbol?: National Research trades on the NASDAQ under the ticker symbol "NRC."
Who are National Research's major shareholders?: National Research's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (13.04%), BlackRock Inc. (4.38%), Conestoga Capital Advisors LLC (2.97%), QV Investors Inc. (1.83%), Renaissance Technologies LLC (1.50%) and State Street Corp (1.34%). Insiders that own company stock include Amandla Mk Trust, Joann M Martin, Jona S Raasch and Kevin R Karas.
View institutional ownership trends.
How do I buy shares of National Research?: Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is National Research's stock price today?: One share of NRC stock can currently be purchased for approximately $44.62.
How much money does National Research make?: National Research (NASDAQ:NRC) has a market capitalization of $1.10 billion and generates $151.57 million in revenue each year. The company earns $31.80 million in net income (profit) each year or $1.17 on an earnings per share basis.
How many employees does National Research have?: The company employs 491 workers across the globe.
Does National Research have any subsidiaries?: The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.
Read More
How can I contact National Research?: National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The official website for the company is www.nrchealth.com. The company can be reached via phone at (402) 475-2525 or via fax at 402-475-9061.

This page (NASDAQ:NRC) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial